These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11174021)

  • 1. Vasopressin and diabetes mellitus.
    Bankir L; Bardoux P; Ahloulay M
    Nephron; 2001 Jan; 87(1):8-18. PubMed ID: 11174021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.
    Bardoux P; Martin H; Ahloulay M; Schmitt F; Bouby N; Trinh-Trang-Tan MM; Bankir L
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10397-402. PubMed ID: 10468619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and urinary concentrating activity in diabetes mellitus.
    Ahloulay M; Schmitt F; Déchaux M; Bankir L
    Diabetes Metab; 1999 Sep; 25(3):213-22. PubMed ID: 10499190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats.
    Bardoux P; Bruneval P; Heudes D; Bouby N; Bankir L
    Nephrol Dial Transplant; 2003 Sep; 18(9):1755-63. PubMed ID: 12937221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus.
    Kusano E; Braun-Werness JL; Vick DJ; Keller MJ; Dousa TP
    J Clin Invest; 1983 Oct; 72(4):1298-313. PubMed ID: 6313759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects.
    Bankir L
    Cardiovasc Res; 2001 Aug; 51(3):372-90. PubMed ID: 11476728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of vasopressin and urine concentrating process in the progression of chronic renal failure.
    Bankir L; Bouby N; Trinh-Trang-Tan MM
    Kidney Int Suppl; 1989 Nov; 27():S32-7. PubMed ID: 2700000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease.
    Lebedeva S; Margaryan A; Smolyarchuk E; Nedorubov A; Materenchuk M; Tonevitsky A; Mutig K
    Front Endocrinol (Lausanne); 2023; 14():1176199. PubMed ID: 37790608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vasopressin in diabetes mellitus-induced hypothalamo-pituitary-adrenal axis activation: studies in Brattleboro rats.
    Zelena D; Mergl Z; Makara GB
    Brain Res Bull; 2006 Mar; 69(1):48-56. PubMed ID: 16464684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin-dependent kidney hypertrophy: role of urinary concentration in protein-induced hypertrophy and in the progression of chronic renal failure.
    Bankir L; Bouby N; Trinh-Trang-Tan MM
    Am J Kidney Dis; 1991 Jun; 17(6):661-5. PubMed ID: 2042645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.
    Luippold G; Beilharz M; Wehrmann M; Unger L; Gross G; Mühlbauer B
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):420-7. PubMed ID: 15887004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus.
    Marshall SM
    Adv Chronic Kidney Dis; 2014 May; 21(3):267-72. PubMed ID: 24780454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vasopressin in regulation of renal kinin excretion in Long-Evans and diabetes insipidus rats.
    Kauker ML; Crofton JT; Share L; Nasjletti A
    J Clin Invest; 1984 Mar; 73(3):824-31. PubMed ID: 6561201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal hemodynamics and its regulation in recently diagnosed type 1 diabetes mellitus (insulin-dependent diabetes mellitus). The effect of hyperglycemia].
    Pelikánová T; Pinsker P; Smrcková I; Stríbrná L; Dryáková M
    Cas Lek Cesk; 1997 Sep; 136(17):533-8. PubMed ID: 9441014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperfiltration in diabetic patients].
    Khristov V; Petrov T; Nikolov M
    Vutr Boles; 1990; 29(2):70-4. PubMed ID: 2122596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S
    Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.